Anika Therapeutics, Inc. (ANIK) Misses Q1 EPS by 3c
Tweet Send to a FriendGet Alerts ANIK Hot Sheet
Price: $14.45 +0.42%
Revenue Growth %: +22.8%
Financial Fact:
Income from operations: 5.01M
Today's EPS Names:
CSS, STV, GIGM, More
Revenue Growth %: +22.8%
Financial Fact:
Income from operations: 5.01M
Today's EPS Names:
CSS, STV, GIGM, More
Trade ANIK Now!
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.14, $0.03 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $14.4 million versus the consensus estimate of $18.2 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- TiVo, Inc. (TIVO) Tops Q1 EPS by 6c; Issues Solid Q2 Rev Outlook
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
